Guillain–Barré syndrome post-SARS-CoV-2 vaccine: a systematic review and data analysis on its clinical, laboratory, electrophysiological, and radiological features

Guillain–Barré syndrome post-SARS-CoV-2 vaccine: a systematic review and data analysis on its clinical, laboratory, electrophysiological, and radiological features

IntroductionGuillain–Barré syndrome (GBS) is a rare disease that affects almost 0.8–1.9 cases per 100,000 people worldwide every year. This is the most prevalent cause of subacute flaccid paralyzing illness today. It is a subacute inflammatory demyelinating polyradiculoneuropathy; the typical scenar...

Full description

Bibliographic Details
Main Authors: Kawther Hadhiah, Ali Alhashim, Hassan A. Al-Dandan, Eman Alhassan, Abdulaziz M. Alqarni, Abdullah Adil A. Memish, Majed Alabdali
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-01-01
Series:Frontiers in Neurology
Subjects:
Guillain–Barré syndrome
cranial polyneuritis
acute sensory ataxia
acute inflammatory demyelinating polyneuropathy
acute motor axonal neuropathy
COVID-19 vaccine
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2024.1332364/full

Internet

https://www.frontiersin.org/articles/10.3389/fneur.2024.1332364/full

Similar Items